Chapter_17
9/17/25About 3 min
### Chapter 17: Causal Survival Analysis
Introduction
- Context: Extends causal inference to time-to-event outcomes (e.g., time until death) where events may occur after study end, necessitating specialized methods for administrative censoring.
- Key shift: Previous chapters focused on outcomes at fixed time points; survival analysis handles events occurring at any time during follow-up.
- Administrative censoring: Intrinsic to survival studies (e.g., study end precludes observing all events). Other censoring types (e.g., loss to follow-up, competing events) require adjustment but are deferred to Part III.
17.1 Hazards and Risks
Technical Points:
- Survival probability: = Proportion surviving beyond time .
- Risk (cumulative incidence): .
- Hazard: Discrete-time hazard defined as (probability of event in interval given survival until ).
- Key difference:
- Risk uses fixed baseline denominator (cumulative events).
- Hazard uses time-varying denominator (at-risk individuals at ).
Fine Points:
- Hazard ratio limitations:
- Varies over time; single summary (e.g., Cox model) is a weighted average, obscuring interpretation.
- Subject to selection bias (conditioning on survival introduces collider bias).
- Preferred contrasts: Survival/risk differences/ratios at specific times (e.g., 5-year survival difference).
17.2 From Hazards to Risks
Technical Points:
- Data structures:
- Wide format: One row per individual.
- Person-time format: One row per person-time interval (enables hazard estimation).
- Time-varying indicator: if (event by ), else .
- Survival from hazards:
. - Estimation:
- Nonparametric: Kaplan-Meier estimator (product-limit).
- Parametric: Logistic model for hazards (e.g., ).
Fine Points:
- Model choices:
- Parametric models (e.g., logistic) smooth unstable nonparametric hazards.
- Semiparametric models (e.g., Cox, AFT) avoid distributional assumptions but impose proportional hazards or other constraints.
17.3 Why Censoring Matters
Technical Points:
- Goal: Estimate (survival if no censoring).
- Challenge: Naive estimation using uncensored individuals introduces selection bias.
- Solution under random censoring:
. - Staggered entry: Adjust for baseline calendar time and confounders.
Fine Points:
- Artificial censoring: Exclude individuals whose event time would be unobserved under alternative treatments to preserve exchangeability.
17.4 IP Weighting of Marginal Structural Models
Technical Points:
- Assumptions: Exchangeability, positivity, consistency.
- Weights: Stabilized IP weights for treated, for untreated.
- MSM for hazards:
. - Survival estimation: Multiply estimated conditional survivals over time.
Results (example):
- 120 months: 80.7% survival under smoking cessation vs. 80.5% under no cessation (difference 0.2%; 95% CI: -4.1%, 3.7%).
17.5 The Parametric g-Formula
Technical Points:
- Standardized survival:
. - Steps:
- Fit parametric hazards model conditional on and .
- Standardize by averaging predictions over covariate distribution .
- G-computation: Predict survival under treatment scenarios using outcome model.
Results (example):
- 120-month survival: 80.4% (cessation) vs. 80.6% (no cessation); difference -0.2% (95% CI: -4.6%, 4.1%).
17.6 G-Estimation of Structural Nested Models
Technical Points:
- Structural AFT model:
(rank-preserving). - G-estimation with censoring:
- Define artificial censoring indicator to handle administrative censoring.
- Find such that (using logistic model).
- Interpretation: = Ratio of median survival times under treatment vs. control.
Results (example):
- (95% CI: -0.223, 0.333); survival time ratio = 1.05.
Fine Points:
- Limitations:
- Rank preservation unrealistic.
- Computationally intensive; few software implementations.
- Alternatives: Structural cumulative failure/time models for rare events.
Key Themes
- Censoring: Central challenge; addressed via hazard/product-limit estimators, IP weighting, g-methods.
- Contrasts: Prefer survival/risk differences over hazard ratios due to interpretability and bias risks.
- Model trade-offs:
- IP weighting: Robust to outcome model misspecification if treatment model correct.
- g-formula: Robust to treatment model misspecification if outcome model correct.
- G-estimation: Theoretically appealing but rarely used due to complexity.
Note: Figures/tables referenced (e.g., 17.1–17.7) illustrate survival curves and causal diagrams but could not be summarized due to lack of visual data.